| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 26 |
| 1 | PALBOCICLIB | 19 |
| 2 | LETROZOLE | 18 |
| 3 | PREDNISONE | 18 |
| 4 | METHOTREXATE SODIUM | 17 |
| 5 | RIBOCICLIB | 16 |
| 6 | ETANERCEPT | 13 |
| 7 | TRASTUZUMAB | 13 |
| 8 | ACETAMINOPHEN | 12 |
| 9 | METHOTREXATE | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE AND SIMETHICONE | 1 | 0.0018 |
| 1 | ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, SIMETHICONE | 1 | 0.0017 |
| 2 | SOYBEAN OIL | 1 | 0.0015 |
| 3 | DATOPOTAMAB DERUXTECAN | 1 | 0.0012 |
| 4 | SACITUZUMAB GOVITECAN | 5 | 0.0010 |
| 5 | TRANDOLAPRIL TABLETS | 2 | 0.0010 |
| 6 | DARUNAVIR 600 MG | 6 | 0.0010 |
| 7 | ADO-TRASTUZUMAB EMTANSINE | 8 | 0.0009 |
| 8 | TRIMIPRAMINE | 1 | 0.0009 |
| 9 | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 38 |
| 1 | Aromatase Inhibitor [EPC] | 31 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 27 |
| 3 | Corticosteroid [EPC] | 25 |
| 4 | Benzodiazepine [EPC] | 15 |
| 5 | HER2/neu Receptor Antagonist [EPC] | 14 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 14 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 14 |
| 8 | Factor Xa Inhibitor [EPC] | 12 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 1 | Aromatase Inhibitor [EPC] | 31 | 0.0003 |
| 2 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 3 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 4 | Estrogen Receptor Antagonist [EPC] | 8 | 0.0002 |
| 5 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 1 | 0.0002 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 14 | 0.0002 |
| 7 | Protease Inhibitor [EPC] | 6 | 0.0001 |
| 8 | Glinide [EPC] | 1 | 0.0001 |
| 9 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |